SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

NVNO

EnVVeno Medical Corporation
NASDAQHealth Care

Latest close: 7.47 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Sep 11, 2026Reported sale · Form 4Francis Duhay · $123.3Open the filing ↗
  2. Sep 11, 2026Notice of sale · Form 144Duhay Francis · Director · $123.0Open the filing ↗
  3. Jul 30, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record36013 flagged findings
Reported transactions (Form 4)36since Dec 5, 2023 · and 5 other holdings
Corporate events (8-K)30since Apr 30, 2019

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

Reverse splits in 5 years

1 reverse split in 5 years (1:35 on Jan 20, 2026) · 1:35 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 360)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Sep 15, 26SCHEDULE 13D/A ↗Stake with intent to influence · amendment
  • Sep 14, 26Form 4 ↗Insider transaction
  • Sep 11, 26Form 144 ↗Notice of proposed sale
  • Aug 21, 26S-3 ↗Securities offering
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Perceptive Advisors LLC · 3.5% · event on Jun 30, 26 · amendment
  • Jul 30, 2610-Q ↗Quarterly report
  • Jul 14, 268-K ↗Current report · Communication to the market
  • Jun 12, 26Form 4 ↗Insider transaction
  • Jun 11, 26Form 144 ↗Notice of proposed sale
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Perceptive Advisors LLC · 10.0% · event on Mar 31, 26 · amendment
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Kingdon Capital Management, L.L.C. · 5.5% · event on Mar 31, 26 · amendment
  • May 6, 2610-Q ↗Quarterly report
  • Apr 29, 268-K ↗Current report · Results · Communication to the market · Other events
  • Mar 26, 2610-K ↗Annual report
  • Mar 13, 26Form 4 ↗Insider transaction
  • Mar 12, 26Form 144 ↗Notice of proposed sale
  • Feb 20, 26SCHEDULE 13D ↗Stake with intent to influence · Braeden Lichti · 5.0%
  • Feb 20, 26SCHEDULE 13D ↗Stake with intent to influence · Braeden Lichti · 5.0%
  • Feb 17, 26SCHEDULE 13G/A ↗Passive stake · Perceptive Advisors LLC · 10.0% · event on Dec 31, 25 · amendment
  • Feb 10, 26SCHEDULE 13G ↗Passive stake · Braeden Lichti · 5.0%
  • Feb 10, 26SCHEDULE 13G ↗Passive stake · Braeden Lichti · 5.0%
  • Feb 4, 268-K ↗Current report · Results · Other events
  • Jan 20, 268-K ↗Current report · Bylaws or fiscal year change
  • Insider transaction · 2 Form 4 filingsshow all 2hide

360 filings on record, the oldest from Mar 13, 17.

Listing the 25 most recent filings of the 360 on record.

8-Ks, explained

Stress5Structure19Governance10
  • Oct 30, 25StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Oct 10, 25StressListing notice (8-K 3.01)+1 more in the same filing8-K 3.01 ↗
  • May 20, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Apr 21, 25GovernanceAuditor change filing (8-K Item 4.01)+1 more in the same filing8-K 4.01 ↗
  • Sep 30, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Oct 12, 23StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Sep 8, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Aug 12, 21StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Feb 24, 21GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 12, 21StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Nov 24, 20StructureSold unregistered shares8-K 3.02 ↗
  • Oct 8, 20StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗

13 older filings not shown · The record reaches back to Jun 6, 18.

Notable in the record

Stress disclosures older than the timeline above. They are individual events from the record, not a complete timeline: there may be more between them.

The full record holds 5 stress filings.

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • Braeden Lichti5.0%Feb 20, 26SCHEDULE 13D ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Thomas A. Satterfield, Jr.9.0%Nov 14, 25SCHEDULE 13G ↗
  • Kingdon Capital Management, L.L.C.5.5%Mar 31, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Braeden Lichti5.0%Feb 10, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Perceptive Advisors LLC3.5%Jun 30, 26SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Nantahala Capital Management, LLC3.5%Sep 30, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

Sale intention announced

On Sep 11, Duhay Francis filed notice of intent to sell up to $123. It is filed under a scheduled plan (10b5-1), arranged in advance.

A notice is not a sale: it may not go ahead, may happen in part, or at a different price.

After the notice, they sold $123 on Sep 11, per their Form 4. That is 100% of the shares announced so far, and the window is still open.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Sep 11, 26Sell$123Francis Duhay↗
  • Jun 11, 26Sell$1KFrancis Duhay↗
  • Mar 12, 26Sell$2KFrancis Duhay↗
  • Dec 11, 25Sell$2KFrancis Duhay↗
  • Sep 15, 25Sell$4KFrancis Duhay↗
  • Dec 31, 24Buy$10KRobert Gray↗
  • Dec 31, 24Buy$250KFrancis Duhay↗
  • Dec 24, 24Buy$16KSanjay Shrivastava↗
  • Dec 19, 24Buy$31KROBERT ANDREW BERMANChief Executive Officer↗
  • Dec 19, 24Buy$24KMatthew Jenusaitis↗
  • Mar 13, 24Sell$52KHamed AlaviChief Technology Officer↗
Stock compensation, tax and giftsshow the other transactionhide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Mar 13, 24Compensation$30KHamed AlaviChief Technology Officer↗

The full record holds 12 transactions and goes back to Jan 18, 23.

Its sector and its market

EnVVeno Medical Corporation among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From EnVVeno Medical Corporation, the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow EnVVeno Medical Corporation in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
360 documents on file, from Mar 13, 2017 to Sep 15, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.